Share-based Payment Arrangement, Expense of Adicet Bio, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Adicet Bio, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Adicet Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2,529,000, a 63% decline year-over-year.
  • Adicet Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $12,390,000, a 47% decline year-over-year.
  • Adicet Bio, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $22,233,000, a 9.7% increase from 2023.
  • Adicet Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $20,259,000, a 18% increase from 2022.
  • Adicet Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $17,126,000, a 37% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Adicet Bio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $12,390,000 $2,529,000 -$4,248,000 -63% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $16,638,000 $2,908,000 -$3,096,000 -52% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $19,734,000 $3,180,000 -$2,499,000 -44% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $22,233,000 $3,773,000 -$1,138,000 -23% 01 Oct 2024 31 Dec 2024 10-K 06 Mar 2025 2024 FY
Q3 2024 $23,371,000 $6,777,000 +$1,217,000 +22% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $22,154,000 $6,004,000 +$981,000 +20% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $21,173,000 $5,679,000 +$914,000 +19% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 $20,259,000 $4,911,000 +$661,000 +16% 01 Oct 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $19,598,000 $5,560,000 +$1,369,000 +33% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $18,229,000 $5,023,000 +$688,000 +16% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $17,541,000 $4,765,000 +$415,000 +9.5% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $17,126,000 $4,250,000 -$30,000 -0.7% 01 Oct 2022 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 $17,156,000 $4,191,000 +$1,662,000 +66% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $15,494,000 $4,335,000 +$1,676,000 +63% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $13,818,000 $4,350,000 +$1,307,000 +43% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $12,511,000 $4,280,000 +$2,633,000 +160% 01 Oct 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $9,878,000 $2,529,000 -$437,000 -15% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $10,315,000 $2,659,000 +$2,308,000 +658% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q1 2021 $8,007,000 $3,043,000 +$2,744,000 +918% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $5,263,000 $1,647,000 01 Oct 2020 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 $2,966,000 +$2,575,000 +659% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $351,000 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $299,000 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q3 2019 $391,000 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3

Adicet Bio, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $22,233,000 +$1,974,000 +9.7% 01 Jan 2024 31 Dec 2024 10-K 06 Mar 2025 2024 FY
2023 $20,259,000 +$3,133,000 +18% 01 Jan 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
2022 $17,126,000 +$4,615,000 +37% 01 Jan 2022 31 Dec 2022 10-K 19 Mar 2024 2023 FY
2021 $12,511,000 +$7,248,000 +138% 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
2020 $5,263,000 +$4,088,000 +348% 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2022 2021 FY
2019 $1,175,000 -$1,304,000 -53% 01 Jan 2019 31 Dec 2019 10-K 12 Mar 2021 2020 FY
2018 $2,479,000 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.